Quickly and cheaply is the goal of Pathogenica, a start-up that proposes to diagnose diseases using sequencing technology, reports MIT's Technology Review. By the end of 2012, the company hopes to have an FDA-approved product to detect the bacteria behind urinary tract infections, all for $10 a test. "The majority [of current tests] require days to get a result, which is frequently too late," says Columbia University's Ian Lipkin, who is on Pathogenica's board, to Tech Review.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.